Features Screener Stocks Charts
Sign In Sign Up

Jenburkt Pharmaceuticals Income Statement

NSE:JENBURKT | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year JENBURKT income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 1.42B 1.52B
Cost of Revenue -304.11M -296.57M
Gross Profit 1.12B 1.22B
Sales, General & Admin -424.89M -455.36M
Operating Income 307.80M 376.65M
Profit Before Tax 351.76M 439.33M
Net Income 259.77M 320.61M
Diluted Shares 4.41M 4.41M
Diluted EPS 58.86 72.65

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025